EP4013412
RIPRETINIB TIL MEÐFERÐAR Á MELTINGARFÆRASTROMALÆXLUM
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
12.8.2020EP published:
28.1.2026EP application number:
20761089.0
EP translation filed:
18.3.2026Grant published:
8.4.2026EPO information:
European Patent Register
Max expiry date:
11.8.2040Expiry date:
11.8.2026
Title in English:
RIPRETINIB FOR TREATING GASTROINTESTINAL STROMAL TUMORSLanguage of the patent:
English
Timeline
Today
12.8.2020EP application
28.1.2026EP Publication
18.3.2026Translation submitted
8.4.2026Registration published
11.8.2026Expires
Owner
Name:
Deciphera Pharmaceuticals, LLCAddress:
200 Smith Street, Waltham, MA 02451, US
Inventor
Name:
SOTO, Rodrigo RuizAddress:
Waltham, MA 02451, US
Name:
ROSEN, OliverAddress:
Waltham, MA 02451, US
Name:
PITMAN, JamaAddress:
Waltham, MA 02451, US
Agent
Name:
Zacco Denmark A/SAddress:
Arne Jacobsens Allé 15, DK
Priority
Number:
201962885797 PDate:
12.8.2019Country:
US
Number:
201962904198 PDate:
23.9.2019Country:
US
Number:
201962926281 PDate:
25.10.2019Country:
US
Number:
201962936018 PDate:
15.11.2019Country:
US
Number:
202062968927 PDate:
31.1.2020Country:
US
Number:
202062968945 PDate:
31.1.2020Country:
US
Number:
202063023921 PDate:
13.5.2020Country:
US
Number:
202063023936 PDate:
13.5.2020Country:
US
Classification
Categories:
A61K 31/4375, A61K 45/06, A61P 35/00